Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Athersys Inc (NASDAQ:ATHX)

1.63
Delayed Data
As of Jul 25
 -0.02 / -1.21%
Today’s Change
1.02
Today|||52-Week Range
2.30
+6.54%
Year-to-Date
No recent news for Athersys Inc.

Today’s Trading

Previous close1.65
Today’s open1.66
Day’s range1.62 - 1.66
Volume394,600
Average volume (3 months)1,140,313
Market cap$181.4M
Dividend yield--
Data as of 07/25/2017

Growth & Valuation

Earnings growth (last year)+10.00%
Earnings growth (this year)-42.59%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+45.19%
P/E ratioNM
Price/Sales7.47
Price/Book12.63

Competitors

 Today’s
change
Today’s
% change
ZYMEZymeworks Inc-0.18-2.43%
MACKMerrimack Pharmaceut...+0.05+3.82%
RDHLRedhill Biopharma Lt...+0.74+7.58%
MNOVMediciNova Inc-0.11-2.03%
Data as of 07/25/2017

Financials

Next reporting dateAugust 10, 2017
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$17.3M
Annual profit (last year)-$15.3M
Net profit margin-88.41%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Gil van Bokkelen
President, Chief Operating Officer &
Secretary
William B. J. Lehmann
Corporate headquarters
Cleveland, Ohio

Forecasts